Eduardo Meaney

Cardiac amyloidosis, constrictive pericarditis and restrictive cardiomyopathy

Eduardo Meaney, Ralph Shabetai, Valmik Bhargava et al. · The American Journal of Cardiology · 1976 · 172 citations

Cardiomyopathy, Heart Failure, Cardiac Amyloidosis +5

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Effects of (−)-epicatechin on molecular modulators of skeletal muscle growth and differentiation

Gabriela Gutiérrez-Salmeán, Theodore P. Ciaraldi, Leonardo Nogueira et al. · The Journal of Nutritional Biochemistry · 2013 · 105 citations · Full text

Skeletal Muscle Growth, Muscle Physiology, Muscle Function +12

METFORMIN, ARTERIAL FUNCTION, INTIMA–MEDIA THICKNESS AND NITROXIDATION IN METABOLIC SYNDROME: THE MEFISTO STUDY

Eduardo Meaney, Agustín Vela, Virginia Corina Samaniego et al. · Clinical and Experimental Pharmacology and Physiology · 2008 · 91 citations

Nutrition, Metabolic Disorder, Cardiometabolic Risk +26

Effects of (−)-epicatechin on a diet-induced rat model of cardiometabolic risk factors

Gabriel Gutiérrez-Salmeán, Pilar Ortiz-Vilchis, Claudia Maria Vacaseydel et al. · European Journal of Pharmacology · 2014 · 82 citations

Obesity, Metabolic Syndrome, Cardiomyopathy +12